Nova Leap Health Stock Current Valuation
| NLH Stock | CAD 0.25 0.01 3.85% |
Valuation analysis of Nova Leap Health helps investors to measure Nova Leap's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, Nova Leap's Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to climb to 21.18 in 2024, whereas Enterprise Value is likely to drop slightly above 16.1 M in 2024. Fundamental drivers impacting Nova Leap's valuation include:
Price Book 0.8364 | Enterprise Value 21.3 M | Enterprise Value Ebitda (126.72) | Price Sales 0.8377 | Forward PE 20.4918 |
Overvalued
Today
Please note that Nova Leap's price fluctuation is out of control at this time. Calculation of the real value of Nova Leap Health is based on 3 months time horizon. Increasing Nova Leap's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Nova stock is determined by what a typical buyer is willing to pay for full or partial control of Nova Leap Health. Since Nova Leap is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nova Stock. However, Nova Leap's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.25 | Real 0.22 | Hype 0.25 |
The intrinsic value of Nova Leap's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Nova Leap's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Nova Leap Health helps investors to forecast how Nova stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nova Leap more accurately as focusing exclusively on Nova Leap's fundamentals will not take into account other important factors: Nova Leap Health Company Current Valuation Analysis
Nova Leap's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Nova Leap Current Valuation | 21.31 M |
Most of Nova Leap's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nova Leap Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Nova Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Nova Leap is extremely important. It helps to project a fair market value of Nova Stock properly, considering its historical fundamentals such as Current Valuation. Since Nova Leap's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Nova Leap's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Nova Leap's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Nova Leap Health has a Current Valuation of 21.31 M. This is 99.85% lower than that of the Health Care Providers & Services sector and 98.7% lower than that of the Health Care industry. The current valuation for all Canada stocks is 99.87% higher than that of the company.
Nova Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nova Leap's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nova Leap could also be used in its relative valuation, which is a method of valuing Nova Leap by comparing valuation metrics of similar companies.Nova Leap is currently under evaluation in current valuation category among its peers.
Nova Leap Current Valuation Drivers
We derive many important indicators used in calculating different scores of Nova Leap from analyzing Nova Leap's financial statements. These drivers represent accounts that assess Nova Leap's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Nova Leap's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 19.9M | 38.3M | 35.9M | 14.3M | 17.5M | 14.3M | |
| Enterprise Value | 24.0M | 41.5M | 40.3M | 17.0M | 18.1M | 16.1M |
Nova Fundamentals
| Return On Equity | -0.0249 | ||||
| Return On Asset | 0.0279 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 21.31 M | ||||
| Shares Outstanding | 86.21 M | ||||
| Shares Owned By Insiders | 40.76 % | ||||
| Number Of Shares Shorted | 12.7 K | ||||
| Price To Book | 0.84 X | ||||
| Price To Sales | 0.84 X | ||||
| Revenue | 26.41 M | ||||
| Gross Profit | 9.98 M | ||||
| EBITDA | 1.23 M | ||||
| Net Income | (1.07 M) | ||||
| Cash And Equivalents | 1.24 M | ||||
| Cash Per Share | 0.02 X | ||||
| Total Debt | 3.97 M | ||||
| Debt To Equity | 64.80 % | ||||
| Current Ratio | 0.58 X | ||||
| Book Value Per Share | 0.21 X | ||||
| Cash Flow From Operations | 1.41 M | ||||
| Short Ratio | 0.72 X | ||||
| Earnings Per Share | (0.02) X | ||||
| Target Price | 0.6 | ||||
| Beta | 1.52 | ||||
| Market Capitalization | 23.28 M | ||||
| Total Asset | 23.95 M | ||||
| Retained Earnings | (1.19 M) | ||||
| Working Capital | (10.37 K) | ||||
| Net Asset | 23.95 M |
About Nova Leap Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nova Leap Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nova Leap using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nova Leap Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Nova Stock Analysis
When running Nova Leap's price analysis, check to measure Nova Leap's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nova Leap is operating at the current time. Most of Nova Leap's value examination focuses on studying past and present price action to predict the probability of Nova Leap's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nova Leap's price. Additionally, you may evaluate how the addition of Nova Leap to your portfolios can decrease your overall portfolio volatility.